Polyrizon Structures Clinical Strategy For PL-14 Ahead Of FDA Pre-Submission Meeting

BenzingaMar 27 08:26 ET

Express News | Polyrizon Ltd - Expects to Initiate Clinical Trials in U.S. and Europe in Late 2025

ReutersMar 27 08:25 ET

Express News | Polyrizon Structures Clinical Strategy for Its Allergy Blocker Ahead of FDA Pre-Submission Meeting

ReutersMar 27 08:25 ET

Polyrizon Announces The Initiation Of Preclinical Studies For Intranasal Benzodiazepines, A Treatment For Acute Repetitive Seizures And Status Epilepticus, Using Its Proprietary Drug Delivery Platform

BenzingaMar 25 16:09 ET

Express News | Polyrizon Expands Drug Delivery Innovation With Preclinical Studies for Epilepsy Rescue Treatment

ReutersMar 25 16:04 ET

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaMar 24 17:05 ET